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Abstract. 
 
Nuclear export of proteins containing leu-
cine-rich nuclear export signals (NESs) is mediated by
the export receptor CRM1/exportin1. However, ad-
ditional protein factors interacting with leucine-rich
NESs have been described. Here, we investigate human
immunodeﬁciency virus type 1 (HIV-1) Rev-mediated
 
nuclear export and Mason-Pﬁzer monkey virus (MPMV)
constitutive transport element (CTE)–mediated nuclear
 
export in microinjected 
 
Xenopus laevis 
 
oocytes. We
show that eukaryotic initiation factor 5A (eIF-5A) is
essential for Rev and Rev-mediated viral RNA export,
but not for nuclear export of CTE RNA. In vitro bind-
ing studies demonstrate that eIF-5A is required for efﬁ-
cient interaction of Rev–NES with CRM1/exportin1
and that eIF-5A interacts with the nucleoporins CAN/
nup214, nup153, nup98, and nup62. Quite unexpect-
edly, nuclear actin was also identiﬁed as an eIF-5A
binding protein. We show that actin is associated with
the nucleoplasmic ﬁlaments of nuclear pore complexes
and is critically involved in export processes. Finally, ac-
tin- and energy-dependent nuclear export of HIV-1
Rev is reconstituted by using a novel in vitro egg ex-
tract system. In summary, our data provide evidence
that actin plays an important functional role in nuclear
export not only of retroviral RNAs but also of host pro-
teins such as protein kinase inhibitor (PKI).
Key words: eIF-5A • CRM1 • nuclear actin • nuclear
export • HIV-1 Rev 
 
Introduction
 
In eukaryotic cells, chromatin is enclosed by a double-lay-
ered membrane system, the nuclear envelope, which sepa-
rates the nuclear genome and its transcriptional apparatus
from the site of protein synthesis. Thus, a constant flow of
macromolecules has to cross the nuclear membranes in
both directions. This transport into and out of the nucleus
 
is mediated by nuclear pore complexes (NPCs),
 
1 
 
which are
elaborate proteinaceous assemblies inserted into the nu-
clear envelope. Their overall structural features, in partic-
ular their striking eightfold rotational symmetry, are re-
markably similar in all eukaryotic cells, and several
constituent proteins, termed nucleoporins, have been
characterized at the molecular level (for review see Stof-
fler et al., 1999). Extensive peripheral structures in the
form of fine filaments extend from the structural core of
the NPC into the cytoplasm and nuclear interior, respec-
tively. The nucleoplasmic NPC-attached filaments form
basket-like assemblies or long cylindrial arrays, which are
especially clearly seen in amphibian oocytes (Franke and
Scheer, 1974; Jarnik and Aebi, 1991; Stoffler et al., 1999).
The filaments projecting away from the cytoplasmic face
of the NPCs are much shorter. Both filamentous NPC-
attached appendages are thought to provide docking sites
and guiding structures for transport cargoes before their
translocation through the central pore channel.
Competition experiments in 
 
Xenopus laevis 
 
oocytes sug-
gested that different classes of RNA (e.g., mRNA, rRNA,
U snRNA, tRNA) are exported from the nucleus by spe-
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cific export factors (Jarmolowski et al., 1994). In general,
RNA export seems to be a multistep mechanism that is
mediated by RNA-binding proteins that contain nuclear
export signals (NESs) (for reviews see Izaurralde and
Adam, 1998; Mattaj and Englmeier, 1998; Stutz and Ros-
bash, 1998; Görlich and Kutay, 1999; Nakielny and Drey-
fuss, 1999). Typically, NESs are recognized by soluble ex-
port receptors that target the transport complexes to the
NPCs. In addition, efficient export requires the action of
several critical factors, of which the GTPase Ran/TC4 and
associated components play a major functional role in de-
termining the direction of nucleocytoplasmic transport
(for reviews see Görlich and Kutay, 1999; Melchior and
Gerace, 1998; Moore, 1998).
To date, the most extensively investigated specific
mRNA export factor is the Rev trans-activator protein of
human immunodeficiency virus type 1 (HIV-1) (for review
see Pollard and Malim, 1998). Rev is a nucleocytoplasmic
shuttle protein that directly binds to its Rev-response ele-
ment (RRE) RNA target sequence, which is part of all un-
spliced and incompletely spliced viral mRNAs. Upon mul-
timerization and subsequent interaction with multiple
cellular cofactors, Rev promotes the translocation of these
mRNAs across the nuclear envelope. The region of Rev
that interacts with cellular cofactors that are required for
nuclear export of Rev–RRE ribonucleoprotein particles
has been defined as either the activation or effector do-
main. This domain contains a short stretch of hydrophobic,
primarily leucine amino acids and constitutes a prototypic
NES that, upon fusion to heterologous protein substrates,
mediates the rapid and active nuclear export of these other-
wise inert proteins (Fischer et al., 1995; Stauber et al., 1995;
Wen et al., 1995; Meyer et al., 1996; Elfgang et al., 1999).
A series of studies has shown that the primary target of
leucine-rich Rev-like NESs is the export receptor CRM1/
exportin1 and, furthermore, that NES-CRM1/exportin1 in-
teraction depends on the presence of RanGTP (Fornerod
et al., 1997a; Fukuda et al., 1997; Ossareh-Nazari et al.,
1997; Stade et al., 1997; Askjaer et al., 1998). Studies with
leptomycin B, a specific inhibitor of CRM1/exportin1
(Kudo et al., 1998, 1999) that prevents the formation of sta-
ble NES-CRM1/exportin1 complexes, demonstrated that
CRM1/exportin1 indeed mediates the translocation of all
Rev-like NES-containing export cargoes through the NPC
(Fornerod et al., 1997a; Fukuda et al., 1997; Ossareh-Naz-
ari et al., 1997; Wolff et al., 1997; Engel et al., 1998; Freed-
man and Levine, 1998; Kudo et al., 1998; Toyoshima et al.,
1998; Wada et al., 1998; Stommel et al., 1999). However,
investigation of HIV-1 Rev function also led to the identi-
fication of another cellular protein, eukaryotic initiation
factor 5A (eIF-5A), that binds to the Rev–NES (Ruhl et
al., 1993). eIF-5A is unique because it is the only cellular
protein known to date to contain the unusual amino acid
hypusine (Park et al., 1993). The hypusine modification,
which does occur in eukaryotes and archaebacteria but not
in eubacteria, is a spermidine-dependent posttranslational
modification that is essential for eIF-5A function, although
its exact function is yet unknown. Distinct eIF-5A mutants
have been described that block Rev activity and thereby
HIV-1 replication in human T cells in trans (Bevec et al.,
1996; Junker et al., 1996). Moreover, microinjection exper-
iments in somatic cells have demonstrated that eIF-5A is
an essential cofactor specifically required for the nuclear
 
export of HIV-1 Rev and the functionally equivalent Rex
protein of human T cell leukemia virus type I (HTLV-I)
(Elfgang et al., 1999). Finally, studies using 
 
Xenopus
 
 oo-
cytes have revealed that eIF-5A accumulates at NPC-asso-
ciated intranuclear filaments, interacts with the export re-
ceptor CRM1/exportin1, and is by itself exported from the
nucleus to the cytoplasm in a leptomycin B–sensitive man-
ner (Rosorius et al., 1999b).
In this study, we investigated the cofactor requirements
for nuclear export of the prototypic HIV-1 Rev RNA ex-
port factor in 
 
Xenopus 
 
oocytes. Microinjection experi-
ments demonstrate that nuclear export of glutathione
 
S
 
-transferase (GST)–Rev–NES fusion proteins, as well as
Rev-mediated RRE RNA export, depends in oocytes, as it
does in mammalian cells, on the Rev cofactor eIF-5A. Fur-
thermore, binding studies using recombinant GST–eIF-5A
and nuclear envelope proteins from oocytes demonstrate
that eIF-5A interacts specifically with nucleoporins that
are known to participate in nuclear export. In the course
of these experiments, we noted that eIF-5A interacts not
only with bona fide nucleoporins but also with nuclear ac-
tin that was localized at the nucleoplasmic face of NPCs,
particularly at the NPC-associated intranuclear filaments.
We present evidence that nuclear actin is functionally in-
volved in nuclear export processes. Finally, by using 
 
Xeno-
pus
 
 egg extract, we establish an energy-dependent in vitro
nuclear export system and demonstrate that actin also par-
ticipates in Rev-NES–mediated nuclear export in this cell-
free system.
 
Materials and Methods
 
Biological Materials
 
Xenopus laevis
 
 were purchased from Nasco. Salamanders of the species
 
Pleurodeles waltl
 
 were provided by Peter Eichhorn (German Cancer Re-
search Center, Heidelberg, Germany). Pieces of 
 
Xenopus 
 
or
 
 Pleurodeles
 
ovary were removed from anesthetized animals and placed in modified
Barth medium (Gurdon, 1991). For studies on the nuclear export of the
protein kinase inhibitor (PKI)–derived NES, 
 
Xenopus
 
 were stimulated by
injection of human chorionic gonadotropine hormone 2 d before removal
of pieces of ovary. Nuclei, nuclear envelopes, and cytoplasmic portions
were manually obtained from full-grown oocytes as described (Krohne
and Franke, 1983). Vero cells were maintained in minimum essential me-
dium (MEM), and HeLa cells constitutively expressing HIV-Rev protein
(Wolff et al., 1995) were maintained in DME containing 5 or 10% FCS,
respectively, at 37
 
8
 
C in a 5% CO
 
2
 
 incubator.
 
Antibodies
 
Antibodies against the following antigens were used: eIF-5A and Rev
(rabbit antibodies; Hammerschmid et al., 1994); CRM1 (rabbit serum;
Kudo et al., 1997); actin (mAb 2G2; Gonsior et al., 1999); phenylalanine–
glycine (FG) repeat nucleoporins (mAb 414; Hiss Diagnostics; Davis and
Blobel, 1986). mAbs specific for GST and BSA or His were obtained from
Sigma-Aldrich or QIAGEN, respectively. The peroxidase or gold-conju-
gated secondary antibodies were from Dianova.
 
Recombinant Proteins
 
GST–Rev, GST–Rev–NES, GST–PKI–NES, wild-type (wt) GST–eIF-5A,
and GST–eIF-5A–M14 fusion proteins expressed in 
 
Escherichia coli
 
 BL21
as well as wt eIF-5A and eIF-5A–M14 were previously described (Bevec
et al., 1996; Elfgang et al., 1999). GST–Rev–NES–green fluorescent pro-
tein (GFP) and GST–RanQ69L was expressed in 
 
E. coli
 
 BL21 and puri-
fied as described (Rosorius et al., 1999a). His-tagged CRM1 was ex-
pressed in 
 
E
 
.
 
 coli
 
 TG1 and affinity purified from crude lysates using Ni
beads (QIAGEN) as essentially described (Guan et al., 2000), with the ex-
ception that a further purification step was added to this protocol by using
size S200 exclusion chromatography (Amersham Pharmacia Biotech). 
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Molecular Clones and In Vitro Synthesis of 
Radiolabeled RNA
 
To generate the expression vector pGEX–RanQ69L, the Ran coding region
was amplified by polymerase chain reaction from pET3dRanQ69L (Klebe
et al., 1993), using appropriate oligonucleotides, and inserted into the
BamHI and EcoRI sites of pGEX–3X (Amersham Pharmacia Biotech). A
sequence encoding the NES of the HIV–Rev protein (LQLPPLERLTL)
was cloned between the BamHI and NheI site of the bacterial expression
vector pGEX–GFP (Rosorius et al., 1999a) by using double-stranded syn-
thetic oligonucleotides, resulting in the plasmid pGEX–Rev–NES–GFP.
The plasmid template pGEM–RRE, which is a derivative of the vector
pGEM–3Zf(
 
1
 
) (Promega), was used for the synthesis of a 252-nucleotide
wt RRE probe and has been described in detail previously (Malim et al.,
1990). The variant vector pGEM–RRE
 
D
 
SLII was used to synthesize a nu-
clear export–deficient RRE probe in which stem loop II (
 
D
 
SLII, lacking
nucleotides 41–105, as shown in Malim et al. [1990]), the high affinity Rev
binding site within the RRE, is deleted. The template and the method
used for the synthesis of the wt constitutive transport element (CTE) and
the double mutant M2/M11 CTE RNA has been described (Ernst et al.,
1997). U6 RNA was synthesized using the vector SP6-U6 (Jarmolowski et
al., 1994). wt and mutant HIV-1 RRE RNA and wt and mutant Mason-
Pfizer monkey virus (MPMV) CTE RNA were radiolabeled by in vitro
transcription using [
 
a
 
-
 
32
 
P]UTP and T7 RNA polymerase (Promega) as de-
scribed previously (Daly et al., 1993a). Likewise, U6 RNA was synthe-
sized using SP6 RNA polymerase (Promega).
 
Microinjection Experiments
 
Just before injection, the defolliculated 
 
Xenopus
 
 oocytes were placed with
the animal hemisphere pointing up in a miniplate containing modified
Barth’s medium and were centrifuged at 1,200 
 
g
 
 for 15 min at 22
 
8
 
C in or-
der to visualize the site of the nucleus. For nuclear export analysis, 20 nl
export substrates was injected into the nuclei of 20 full-grown 
 
Xenopus
 
oocytes that had been injected 1 h before with either purified antibodies
against eIF-5A (IgG; 0.5 mg/ml), purified antibodies against actin (IgM;
1 mg/ml), nonspecific rabbit IgG (0.5 mg/ml), nonspecific mouse IgM (1
mg/ml), the actin-binding drugs latrunculin B (3 mM; Calbiochem), or
swinholide A (3 mM; Alexis). Injected export substrates were GST–Rev–
NES or GST–PKI–NES (0.1 mg/ml), RRE RNA (0.6 
 
m
 
M wt or mutant
RRE RNA, 0.8–1.0 
 
3 
 
10
 
6
 
 cpm, incubated 30 min on ice with Rev recombi-
nant protein as described by Fischer et al. [1995]) and CTE RNA (wt or
mutant 
 
32
 
P-labeled CTE RNA, 10
 
7
 
 cpm). In some experiments, wt eIF-5A
or eIF-5A–M14 proteins (using a 10-fold molar excess over the coinjected
GST–Rev–NES or GST–Rev fusion proteins) were preincubated for 1 h
at 4
 
8
 
C before microinjection into the oocyte nuclei. BSA (1 mg/ml; Sigma-
Aldrich) or 
 
32
 
P-labeled U6 RNA were coinjected as internal markers for
monitoring the site of injection. For the microinjection experiments in
Vero cells, GFP–Rev–NES–GST fusion protein (1 mg/ml) was coinjected
into the nuclei with actin antibodies (IgM, 1 mg/ml) or with nonspecific
mouse IgM (1 mg/ml).
 
Preparation and Analysis of Injected Samples
 
After an incubation time of 2 h, nuclei and cytoplasms from 
 
Xenopus
 
 oo-
cytes were manually isolated, and the samples prepared for protein gel
electrophoreseis as described (Dabauvalle and Franke, 1982). The pro-
teins were separated by SDS-PAGE (Thomas and Kornberg, 1975), using
18% acrylamide. For immunoblots, polypeptides were transferred electro-
phoretically to nitrocellulose filters. Nonspecific protein binding sites
were blocked by overnight incubation with TBST (10% nonfat dry milk in
150 mM NaCl, 0.05% Tween-20, 10 mM Tris-HCl, pH 8.0) at 4
 
8
 
C. After
several washes in TBST, the nitrocellulose filters were incubated for 2 h at
room temperature with GST antibodies (diluted 1:1,000 in TBST). After
washing again in TBST, the nitrocellulose filters were then incubated for
1 h at room temperature with the appropriate secondary antibodies cou-
pled to peroxidase (diluted 1:10,000 in TBST containing 10% dry milk).
After several further washes in TBST, the nitrocellulose filters were incu-
bated for 2 h at room temperature with BSA antibodies (diluted 1:500 in
TBST). The nitrocellulose filters were then washed several times in TBST
and incubated for 1 h at room temperature with appropriate secondary
antibodies coupled to peroxidase (diluted 1:10,000 in TBST containing
10% dry milk). Bound antibodies were visualized using the enhanced
chemical luminescence detection system (ECL).
For RNA analysis, nuclei and cytoplasms were manually isolated as de-
scribed (Dabauvalle and Franke, 1982). RNA from each fraction was ex-
 
tracted separately by using peqGOLD TriFast™ according to the manu-
facturer’s protocol (Peqlab). Labeled RNA molecules were separated by
electrophoresis on denaturating polyacrylamide gels (6% acrylamide/bis-
acrylamide 29:1; 8 M urea) and visualized by autoradiography.
 
Overlay Blot Analyses and Pull-Down Experiments
 
Proteins obtained from 100 manually isolated nuclear envelopes were sep-
arated by SDS-PAGE (Thomas and Kornberg, 1975), using 12% acryl-
amide, and processed for overlay blot assays as described previously
(Lounsbury et al., 1994), using GST–eIF-5A. Bound proteins were visual-
ized by incubation with anti-GST antibodies (diluted 1:1,000). Then, the
nitrocellulose filters were stripped of bound antibodies and reprobed as
described in the manufacturer’s protocol (Amersham Pharmacia Biotech)
with mAb 414 (diluted 1:1,000), antiactin antibodies (diluted 1: 1,000), or
anti-CRM1 antiserum (diluted 1:250).
Pull-down experiments were performed as described previously (Yang
et al., 1998), by using GST, wt GST–eIF-5A, GST–eIF-5A–M14, or GST–
Rev–NES fusion proteins (1 
 
m
 
g/
 
m
 
l) and 150 manually isolated oocyte nu-
clei or total oocyte extract (corresponding to 150 oocytes). In another set
of experiments, GST or GST–Rev–NES fusion protein (1 
 
m
 
g/
 
m
 
l) coupled
to glutathione–Sepharose beads was incubated with a 10-fold molar excess
of wt eIF-5A or eIF-5A–M14 protein before incubation with oocyte ex-
tract or with His-tagged CRM1 fusion protein (0.5 
 
m
 
g/
 
m
 
l). For the pull-
down experiments with His-tagged CRM1, the glutathione–Sepharose
beads were saturated by using 5% BSA, and the binding was performed
with or without addition of the GTPase-deficient RanQ69L mutant. The
bound and unbound proteins were separated by 12% SDS-PAGE, fol-
lowed by silver staining (Switzer et al., 1979) or by immunoblotting us-
ing anti-CRM1 antiserum (diluted 1:250), anti-His antibodies (diluted
1:1,000), anti–eIF-5A antibodies, mAB 414, or antiactin antibodies, di-
luted as described above.
 
Mass Spectrometry Analysis and Peptide Sequencing
 
Proteins from manually isolated oocyte nuclear envelopes were separated
by electrophoresis through a 12% SDS-PAGE gel and stained with Coo-
massie brilliant blue, and the 45-kD band was excised. Tryptic digestion of
the protein sample within the polyacrylamide matrix was performed as
previously described (Eckerskorn and Lottspeich, 1989). After extensive
washing in water, the gel pieces were lyophylized and resoaked with
buffer containing endoproteinase LysC (Boehringer). The resulting pep-
tide fragments were eluted with formic acid/acetonitrile/water (5:50:45).
Peptide mass fingerprinting on a Reflex III MALDI mass spectrometer
(Bruker) identified the sample protein as actin. This was further con-
firmed by peptide sequencing after separation of the peptide mixture by
reversed phase HPLC on a Microcart 150-1 Purospher C18 5-
 
m
 
m column
(Merck). The eluents used in the HPLC were solvent A (0.1% trifluoro-
acetic acid in water) and solvent B (0.1% trifluoroacetic acid in acetoni-
trile). The gradient was developed in 0–60% solvent B for 60 min at a flow
rate of 60 
 
m
 
l/min. Eluted peptides were detected at 206 nm, collected man-
ually, and sequenced in an amino acid sequencer (PE Biosystems) ac-
cording to the manufacturer’s instructions. The sequence obtained
([D]SYVGDEAQSK) fitted the amino acid sequence of 
 
X.
 
 
 
laevis
 
 actin
isoforms, perfectly.
 
Immunogold Electron Microscopy
 
Manually isolated and unfixed nuclear envelopes were incubated with ei-
ther the antiactin antibody 2G2 (diluted 1:200) alone or in combination
with anti–eIF-5A antibodies (diluted 1:250), followed by incubation for
2 h with secondary antibodies coupled to 6- or 12-nm gold particles (di-
luted 1:10). Procedures used for preembedding immunoelectron micros-
copy of isolated nuclear envelopes from 
 
Xenopus
 
 and 
 
Pleurodeles
 
 oocytes
have been described previously.
 
Nuclear Export In Vitro
 
Nuclei from HeLa cells constitutively expressing HIV-1 Rev protein (Wolff et
al., 1995) were isolated as described (Krohne et al., 1981). Extract was pre-
pared from activated 
 
Xenopus
 
 eggs using standard protocols, which include
the use of cytochalasin B (Dabauvalle et al., 1991; Newmeyer and Wilson,
1991) or, alternatively, without this actin-binding drug. The nuclei were incu-
bated in egg extract for 1 h with or without the addition of an ATP regenerat-
ing system (2 mM ATP, 20 mM phosphocreatine, 50 
 
m
 
g/ml creatine kinase).
After incubation, the probes were centrifuged onto coverslips and prepared
for immunofluorescence microscopy as described (Dabauvalle et al., 1991). 
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Results
 
eIF-5A Is a Critical Factor Involved in Rev-dependent 
Nuclear Export in Xenopus Oocytes
 
Microinjection of export substrates into the nucleus of 
 
Xe-
nopus
 
 oocytes and the subsequent monitoring of their nu-
cleocytoplasmic distribution provides a powerful tool to
investigate nuclear export. Here, we have used this tech-
nology to investigate the cofactor requirements for nu-
clear export of the HIV-1 Rev trans-activator protein. It
has been shown that treatment of 
 
Xenopus 
 
oocytes with
the drug leptomycin B, which directly binds to the general
export receptor CRM1/exportin1 and prevents its interac-
tion with leucine-rich NESs (Kudo et al., 1998, 1999), effi-
ciently blocks nucleocytoplasmic translocation of Rev
(Fornerod et al., 1997a). In contrast, however, eIF-5A,
which is another cellular Rev cofactor, has so far not been
investigated in detail with respect to Rev-mediated nu-
clear export in 
 
Xenopus
 
 oocytes. Some discrepancies exist
Figure 1. eIF-5A is required for nuclear export of GST–Rev–
NES and Rev-mediated RNA export, but not for CTE RNA and
GST–PKI–NES export in Xenopus oocytes. (A) To analyze in-
teraction of the Rev–NES with eIF-5A in solution, glutathione–
Sepharose beads coupled to GST–Rev (lanes 1 and 19) or, as a
control, GST (lanes 2 and 29) were incubated with the extract of
150 Xenopus oocytes, pelleted, and then processed for immunoblotting with antibodies to eIF-5A. Bound proteins are shown in lanes 1
and 2, and the unbound material are shown in lanes 19 and 29. eIF-5A binds specifically to GST–Rev–NES (compare lanes 1 and 19).
Molecular mass standards are indicated in kD. (B) Oocyte injection protocol. After injection and incubation, oocytes were manually
dissected in nuclear (N) and cytoplasmic (C) fractions. (C) Proteins were separated by 18% SDS-PAGE, and blots were probed with
antibodies against GST and BSA. In the presence of control IgG, within 2 h, most GST–Rev–NES migrates from the nucleus to the cy-
toplasm (lanes 1 and 2). In contrast, in the presence of antibodies to eIF-5A, the nuclear export of GST–Rev–NES is largely inhibited
(lanes 3 and 4). Coinjection of wt eIF-5A protein overcomes the blocking effect of anti–eIF-5A antibodies on GST–Rev–NES export
(lanes 5 and 6). To monitor the site of injection, the export substrate was injected along with BSA, which is not exported. The exclusive
presence of BSA in the nuclei confirms the specificity of the nuclear injections (lanes 1, 3, and 5). Molecular mass standards are indi-
cated in kD. (D and E) RNA was analyzed by 8 M 6% acrylamide urea gel electrophoresis followed by autoradiography. (D) In the
presence of Rev, the RRE RNA is exported (lane 2). In contrast, antibodies against eIF-5A inhibit this export (lane 4). (E) Antibodies
against eIF-5A do not prevent the nuclear export of CTE RNA (lanes 2 and 4), indicating that eIF-5A is not involved in the CTE RNA
export pathway. Nuclear injected CTE M2/M11 RNA mutant remains in the nuclei (lanes 1 and 3). The nuclear localization of U6-
RNA confirms the accuracy of nuclear injections. (F) Nuclear export of the injected GST–PKI–NES fusion protein was analyzed as
shown in B. The export of GST–PKI–NES was unaffected by the presence of anti–eIF-5A antibodies (lanes 2 and 4), confirming that
eIF-5A is not involved in PKI-NES–mediated nuclear export. 
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with respect to Rev function in oocytes. In particular, Rev
function could not be detected in oocytes that were micro-
injected with expression plasmids encoding Rev and a
Rev-responsive CAT reporter (Ruhl et al., 1993). In con-
trast, nucleocytoplasmic translocation of a radiolabeled
RRE RNA probe, which was comicroinjected with high
amounts of recombinant Rev protein, has been reported in
other studies (Fischer et al., 1995; Stutz et al., 1996). Al-
though the reason for this discrepancy is not known, the
simplest explanation may be the significantly different
sensitivities of the assay systems used (e.g., Rev trans-acti-
vation versus Rev-mediated nuclear RNA export; for a de-
tailed discussion of Rev activities in oocytes also see Roso-
rius et al., 1999b).
The Rev–NES has been shown previously to interact
with HeLa cell–derived and recombinant eIF-5A (Ruhl et
al., 1993; Bevec et al., 1996). To verify the interaction of
the Rev–NES with oocyte-derived eIF-5A, we first per-
formed binding studies in solution. For this, purified GST–
Rev–NES fusion protein was immobilized on glutathione–
Sepharose beads and incubated with total protein extracts
from 
 
Xenopus
 
 oocytes. The beads were then pelleted by
centrifugation, and the bound and unbound material was
analyzed by Western analysis using antibodies directed
against eIF-5A (Elfgang et al., 1999). As shown, eIF-5A
bound the GST–Rev–NES fusion protein (Fig. 1 A, com-
pare lanes 1 and 1
 
9
 
) but not GST alone (Fig. 1 A, compare
lanes 2 and 2
 
9
 
).
To characterize the role of eIF-5A in oocytes, we next
tested anti–eIF-5A antibodies for their ability to interfere
with Rev–NES-mediated nuclear export. For this, nonspe-
cific immunoglobulin G (IgG) or anti–eIF-5A antibodies
were microinjected into oocyte nuclei (Fig. 1 B). After 1 h
of incubation, recombinant GST–Rev–NES export sub-
strate, together with BSA (export-deficient injection con-
trol), was microinjected into the same nuclei. After an-
other 2-h period of incubation, the injected oocytes were
dissected into nuclear and cytoplasmic components. The
proteins from each fraction were separated by SDS-
PAGE, transferred to nitrocellulose, and probed with anti-
GST and anti-BSA antibodies. As expected and shown in
Fig. 1 C, the BSA injection control was found exclusively
in the nuclei (lanes 1, 3, and 5). In agreement with previous
studies (Fornerod et al., 1997a; Ullman et al., 1999), nu-
clear injected GST–Rev–NES fusion protein was rapidly
exported to the cytoplasm in presence of nonspecific IgG
(Fig. 1 C, lanes 1 and 2). In sharp contrast, however, injec-
tion of anti–eIF-5A antibodies resulted in an effective
block of the nuclear export of GST–Rev–NES fusion pro-
tein (Fig. 1 C, lanes 3 and 4). To demonstrate the specific-
ity of the used anti–eIF-5A antibodies, we next tested the
ability of wt eIF-5A to overcome this inhibitory effect. As
shown (Fig. 1 C, lanes 5 and 6), comicroinjection of GST–
Rev–NES together with wt eIF-5A protein clearly restored
the nuclear export of the GST–Rev–NES fusion protein.
Next, we used the same experimental design to inves-
tigate Rev-mediated nuclear export of HIV-1–derived
RNA (Fig. 1 B). For this, the RRE RNA target sequence
was radiolabeled by in vitro transcription and microin-
jected together with recombinant Rev protein into oocyte
nuclei. Coinjection of export-deficient radiolabeled U6
RNA served as the control for accurate nuclear injection
in these experiments (Hamm and Mattaj, 1989). 2 h after
 
microinjection of the RNA export substrate, the oocyte
nuclear components and cytoplasmic components were
separated, and localization of the various RNAs was ana-
lyzed by gel electrophoresis and autoradiography. In
agreement with the data discussed above, efficient nuclear
export of RRE RNA occurred in the presence of nonspe-
cific IgG (Fig. 1 D, lanes 1 and 2), whereas its export was
inhibited by anti–eIF-5A antibodies (Fig. 1 D, lanes 3 and
4). Notably, translocation of RRE RNA across the nuclear
envelope was only observed in the presence of Rev trans-
activator protein (data not shown).
All retroviruses have to export unspliced intron-con-
taining RNA from the nucleus to the cytoplasm. However,
simple retroviruses such as the type D retrovirus MPMV
do not encode Rev-like activities. In the RNA genome of
these viruses is a cis-active structure, termed the CTE,
which mediates efficient nuclear export of their unspliced
RNAs (Bray et al., 1994; Ernst et al., 1997; Pasquinelli et
al., 1997; Saavedra et al., 1997). CTE-mediated export de-
pends exclusively on endogenous cellular factors. Indeed,
the TAP protein, which is a human protein involved in
mRNA transport, was recently found to bind to the CTE
and stimulate nuclear export of CTE-containing viral
RNAs (Grüter et al., 1998; Braun et al., 1999; Bachi et al.,
2000). Importantly, the CTE-TAP–dependent nuclear
RNA export pathway appears to be distinct from the spe-
cific RNA export pathway that is accessed by the HIV-1
Rev protein (Pasquinelli et al., 1997; Bogerd et al., 1998;
Kang and Cullen, 1999; Zolotukhin and Felber, 1999).
Thus, inhibition of Rev export should not negatively affect
the translocation of CTE-containing RNA across the oo-
cyte nuclear envelope.
To test this, we investigated the effect of anti–eIF-5A
antibodies on nuclear export of the prototypic MPMV
CTE (Ernst et al., 1997). As shown in Fig. 1 E, nuclear ex-
port of wt CTE RNA was easily detectable in the presence
of nonspecific control IgG, whereas, in contrast, a coin-
jected export-deficient CTE deletion mutant (M2/M11;
Pasquinelli et al., 1997) remained in the nuclear compart-
ment of the injected oocytes (lanes 1 and 2). Coinjection of
U6 RNA served as the injection control in these experi-
ments. In the presence of anti–eIF-5A antibodies, nuclear
export of CTE RNA continued (Fig. 1 E, lanes 3 and 4).
Note that, under the same conditions, Rev-mediated RRE
RNA export was completely blocked (Fig. 1 D, lanes 3 and
4). These results demonstrate that eIF-5A does not partici-
pate in the export of CTE RNA.
Previously, we have reported that, in somatic cells, eIF-
5A is required for the nuclear export of the Rev–NES and
Rex–NES, but not for the export of the PKI–NES (Elfgang
et al., 1999). Therefore, we tested anti–eIF-5A antibodies
for their ability to interfere with PKI-NES–mediated nu-
clear export in oocytes. To our initial surprise, the micro-
injected GST–PKI–NES fusion protein remained in the
microinjected nuclei in absence of anti–eIF-5A antibodies,
even after extended periods of incubation (data not
shown). However, when we microinjected oocytes derived
from hormone-induced animals, the GST–PKI–NES ex-
port cargo was rapidly exported from the nucleus to the
cytoplasm (Fig. 1 F, lanes 1 and 2). These data already in-
dicated that, in oocytes, significant differences exist with
respect to the regulation of PKI-NES– versus Rev-NES–
mediated nuclear export. Importantly, however, comicro- 
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injection of anti–eIF-5A antibodies did not abrogate nu-
clear export of the GST–PKI–NES export substrate (Fig. 1
F, lanes 3 and 4), which is in full agreement with the data
raised in somatic cells (Elfgang et al., 1999).
Constitutive expression of an eIF-5A mutant gene (eIF-
5A–M14) in human T cells has been previously shown to
efficiently inhibit HIV-1 replication in these cells (Bevec
et al., 1996; Junker et al., 1996). Subsequently, microinjec-
tion studies in somatic cells revealed that eIF-5A–M14 in-
terferes with the nuclear export activity of Rev (Bevec et
al., 1996; Elfgang et al., 1999), explaining its pronounced
inhibitory phenotype on virus replication. Therefore, we
next included wt eIF-5A and eIF-5A–M14 mutant protein
in our oocyte microinjection studies, as outlined in Fig. 2
A. The GST–Rev–NES export substrate was incubated ei-
ther with PBS, wt eIF-5A, or eIF-5A–M14 protein for 1 h
(using a 10-fold M excess over the GST–Rev–NES fusion
protein), in order to allow binding of the Rev–NES to the
recombinant eIF-5A proteins. Subsequent nuclear micro-
injection demonstrated that the eIF-5A–M14 mutant pro-
tein also inhibited GST–Rev–NES export in oocytes (Fig.
2 B, lanes 5 and 6). This inhibitory phenotype was not ob-
served in the presence of PBS (Fig. 2 B, lanes 1 and 2, neg-
ative control) or wt eIF-5A protein (Fig. 2 B, lanes 3 and
4). Moreover, the presence of eIF-5A–M14 also blocked
Rev-mediated RRE RNA export (Fig. 2 C, lanes 5 and 6).
As expected, nuclear export of CTE RNA was not inhib-
ited by eIF-5A–M14 (Fig. 2 D, lanes 5 and 6).
Together, these data show that eIF-5A plays an essential
role in Rev and Rev-dependent RRE RNA export in 
 
Xe-
nopus
 
 oocytes. To date, however, it is not clear which pre-
cise function eIF-5A executes during the nuclear export of
Rev–RRE-containing ribonucleoproteins. In particular, it
is not known at which stage during nucleocytoplasmic
translocation eIF-5A mutant proteins (e.g., M14) block
Rev export. Therefore, we next investigated whether or
not eIF-5A–M14 by itself is exported from the nuclear to
the cytoplasmic compartment. As depicted in Fig. 3 A, wt
GST–eIF-5A or GST–eIF-5A–M14 fusion proteins were
microinjected into oocyte nuclei, and localization of the in-
jected proteins was analyzed using specific antibodies, 2 h
after injection. In agreement with previous data using so-
matic cells (Rosorius et al., 1999b), a significant amount of
the nuclear-injected wt GST–eIF-5A protein was trans-
ported to the cytoplasm in these experiments (Fig. 3 B,
lanes 1 and 2). In sharp contrast, however, the GST–eIF-
5A–M14 protein remained predominantly in the injected
oocyte nuclei (lanes 3 and 4). It has recently been shown
by overlay blot assays and binding studies in solution that
unmodified eIF-5A is able to interact with CRM1/ex-
portin1 (Rosorius et al., 1999b). In our next set of experi-
ments, therefore, we analyzed the binding of wt eIF-5A
and eIF-5A–M14 to CRM1/exportin1 using GST–eIF-5A
fusion proteins and total protein extracts from stage VI
oocytes, which are a rich source for CRM1/exportin1. The
use of oocyte extracts in these experiments has the addi-
tional advantage that these extracts also contain the cofac-
tors that are possibly required for the formation of nuclear
export complexes (e.g., RanGTP). wt GST–eIF-5A or
GST–eIF-5A–M14 fusion proteins were immobilized on
glutathione–Sepharose beads and incubated with oocyte
protein extracts. The beads were then pelleted by centrifu-
gation, and the bound and unbound material was analyzed
by Western blots using antiserum raised against CRM1/
Figure 2. The eIF-5A mutant protein M14 inhibits the nuclear ex-
port of GST–Rev–NES and RRE RNA but not of CTE RNA. (A)
Oocyte injection protocol. Before nuclear injection, the export sub-
strate was incubated for 1 h with wt or mutant eIF-5A or, as a con-
trol, with PBS alone. (B) Nuclear (N) and cytoplasmic (C) proteins
were separated by 18% SDS-PAGE, transferred to nitrocellulose,
and probed with antibodies to GST and BSA. In the presence of
PBS or wt eIF-5A protein, GST–Rev–NES migrates efficiently to
the cytoplasm (lanes 2 and 4). In contrast, the export is blocked in
the presence of the eIF-5A mutant M14 (lane 6). The nonexport-
able protein BSA was injected along with the export substrate to
verify the specificity of nuclear injections. Molecular mass standards
are indicated in kD. (C and D) RNA was analyzed by 8 M 6% acryl-
amide urea gel electrophoresis followed by autoradiography. (C)
In the presence of PBS or wt eIF-5A, the Rev–RRE RNA is ex-
ported (lanes 2 and 4). In contrast, export is inhibited in presence of
the mutant protein eIF-5A–M14 (lane 6). (D) Nuclear export of
CTE RNA is not prevented by PBS (lane 2), wt eIF-5A (lane 4), or
eIF-5A–M14 (lane 6), indicating that eIF-5A is not involved in the
CTE RNA export pathway. Nuclear injected CTE M2/M11 mutant
RNA remains in the nuclei (lanes 1, 3, and 5). The nuclear localiza-
tion of U6-RNA confirms the accuracy of nuclear injections. 
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exportin1 (Kudo et al., 1997). As shown in Fig. 3 C,
CRM1/exportin1 bound wt GST–eIF-5A protein (lane 1)
but not GST alone (lane 3). Interestingly, the Rev inhibi-
tory mutant eIF-5A–M14 clearly failed to interact with
CRM1/exportin1 (lane 2). Thus, the inability of the eIF-
5A–M14 protein to interact with CRM1/exportin1 (Fig. 3
C) correlates with its diminished nuclear export activity.
Please also note that the 
 
z
 
66-kD cross-reacting protein
appears to be a specific CRM1–exportin 1 degradation
product (Rosorius et al., 1999b). To further clarify the
mode of action of the inhibitory phenotype of eIF-5A–
M14 on Rev export (Bevec et al., 1996; Elfgang et al.,
1999), we investigated whether eIF-5A acts as a Rev–
CRM1/exportin1 bridging factor (Fig. 3 D). GST–Rev–
NES fusion protein was immobilized on glutathione–
Sepharose beads and then incubated with a 10-fold M
excess of either wt eIF-5A or eIF-5A–M14 to allow sat-
uration of the Rev–NES. Next, oocyte extract was added,
and the relative amount of bound and unbound CRM1/
exportin1 was determined as before. As shown in Fig. 3 D,
CRM1/exportin1 only bound efficiently to the Rev–NES
in the presence of wt eIF-5A (lane 1) and almost com-
pletely failed to interact with the NES in the presence of
eIF-5A–M14 (lane 2). Next, we substituted the oocyte ex-
tract by recombinant CRM1/exportin1 and RanGTP (Fig.
3 E). As shown, His-tagged CRM1/exportin1 only bound
to GST–Rev–NES fusion protein in the presence of wt
eIF-5A and the GTP-bound form of Ran (GST-RanQ69L;
compare lanes 1, 3, and 5). Again, no interaction of
CRM1/exportin1 with the Rev–NES was visible in pres-
ence of eIF-5A–M14 (lane 2). Finally, formation of
CRM1/exportin1-containing nuclear export complexes did
not occur in absence of the Rev–NES (lane 4). Note that
the observed CRM1 degradation products of 
 
z
 
66 and 
 
z
 
49
kD were also detectable in these experiments using
CRM1-specific antibodies (not shown).
The combined data demonstrate that eIF-5A partici-
pates specifically in nuclear export of the HIV-1 Rev RNA
transport factor but not in MPMV CTE–mediated viral
RNA export. Apparently, eIF-5A mediates efficient inter-
Figure 3. The eIF-5A mu-
tant protein M14 is not ex-
ported and is unable to bind
the export factor CRM1–
exportin 1. (A) Oocyte injec-
tion protocol. 2 h after nu-
clear injection of wt eIF-5A
or mutant protein M14, oo-
cytes were manually dis-
sected into nuclear (N) and
cytoplasmic (C) fractions.
(B) Proteins were separated
by 18% SDS-PAGE, and
blots were analyzed with an-
tibodies to GST and BSA. A
substantial fraction of the in-
jected wt GST–eIF-5A mi-
grates into the cytoplasm
within 2 h (lane 2). In con-
trast, most of the eIF-5A mu-
tant protein M14 remains in
the nuclei (compare lanes 3
and 4). The exclusive pres-
ence of BSA in the nuclei
confirms the specificity of the
nuclear injections. (C) Inter-
action of wt eIF-5A and the
mutant M14 with CRM1 as
determined by pull-down as-
say. Glutathione–Sepharose
beads coupled to the GST
proteins indicated were incu-
bated with oocyte extract.
Bound and unbound proteins
were resolved by SDS-PAGE and analyzed by immunoblotting experiments with anti-CRM1 antiserum. Bound proteins are shown in
lanes 1–3, unbound proteins are shown in lanes 19–39. CRM1 binds to the wt form of eIF-5A (lane 1) but not to the M14 mutant (lane 2)
and GST alone (lane 3). (D) Role of eIF-5A for interaction between CRM1 and Rev–NES was analyzed by pull-down assay. GST–
Rev–NES coupled to glutathione–Sepharose beads was incubated with wt eIF-5A/eIF-5A–M14 before incubation with oocyte extract.
Bound (lanes 1–3) and unbound (19–39) proteins were analyzed as described above. CRM1 binds to GST–Rev–NES only in the pres-
ence of the wt form of eIF-5A (lane 1) but not of the M14 mutant (lane 2). (E) Role of eIF-5A for interaction between recombinant
CRM1 fusion protein and Rev–NES was analyzed by pull-down assay. GST–Rev–NES or GST alone coupled to glutathione-Sepharose
beads were incubated in various combinations with RanGTP (GST-RanQ69L), wt eIF-5A, or eIF-5A–M14 before addition of recombi-
nant His-tagged CRM1. Bound (lanes 1–5) and unbound (lanes 19–59) CRM1 was visualized by using His-specific antibodies. CRM1 fu-
sion protein binds to GST–Rev–NES only in the presence of the wt form of eIF-5A and RanGTP (lane 1 versus lanes 3 and 5) but not in
presence of the M14 mutant (lane 2) and not to GST (lane 4). The 66- and 45-kD components apparently represent CRM1 degradation
products. Molecular mass standards are indicated in kD. 
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action of the Rev–NES with CRM1/exportin1. Moreover,
the previously reported eIF-5A–M14 mutant does not
bind to CRM1/exportin1, thereby preventing efficient in-
teraction of the Rev–NES with CRM1/exportin1. This
binding defect of the eIF-5A mutant explains its previ-
ously observed ability to inhibit nuclear export of Rev.
 
Interaction of the Rev Cofactor eIF-5A with Nuclear 
Envelope Proteins
 
It has already been reported that eIF-5A accumulates at
the nucleoplasmic periphery of the NPC, particularly at
the nucleoplasmic filaments that emanate from the NPC
surface into the nucleoplasm (Rosorius et al., 1999b).
These filaments might serve as docking sites at which ex-
port cargoes initially interact with the NPC before their
exit through the pore channel (e.g., Franke and Scheer,
1974; Cordes et al., 1993). After we had established that
eIF-5A is required for Rev export in 
 
Xenopus
 
 oocytes, we
used GST–eIF-5A fusion protein as a bait in order to iden-
tify components of the NPC that participate in this export
pathway. Therefore, we manually isolated nuclear enve-
lopes from oocytes. The nuclear envelope proteins were
separated by SDS-PAGE, transferred onto nitrocellulose
filters, renatured, and incubated with GST–eIF-5A fusion
protein or GST alone as control. Bound proteins were de-
tected with anti-GST antibodies. As shown in Fig. 4 A,
GST–eIF-5A interacted with several distinct oocyte nu-
clear envelope proteins (lane 2, denoted by dots), whereas
GST alone did not bind (lane 1). To identify these poten-
tial eIF-5A interaction partners, the nitrocellulose filters
were stripped of the bound proteins and reprobed with
specific antibodies. In agreement with the data presented
above (Fig. 3 C), the signal detected at 
 
z
 
110 kD was iden-
tified as the export receptor CRM1/exportin1 (lane 3),
which in fact has been reported to accumulate at both the
nucleoplasmic and cytoplasmic face of the NPC, particu-
larly associating with the nucleoporin CAN/nup214 (For-
nerod et al., 1996, 1997b). The use of the mAb 414, which
recognizes several nucleoporins containing multiple copies
of FG repeats revealed that the nucleoporins CAN/
nup214, nup153, nup98, and nup62 are potential eIF-5A
binding partners (Fig. 4 A, lane 4). These interactions
were reproduced in blot assays, using two-dimensional
gels (data not shown), allowing us to unequivocally con-
firm that the abundant band observed at 
 
z
 
110 kD in the
overlay blot (Fig. 4 A, lane 2) is in fact CRM1/exportin1
Figure 4. Interaction of eIF-5A with nuclear envelope proteins
as determined by overlay assays and pull-down experiments. (A)
Nuclear envelopes were manually isolated from Xenopus oo-
cytes, and the proteins were separated by 12% SDS-PAGE,
transferred to nitrocellulose, and incubated with GST alone (lane
1) or GST–eIF-5A fusion protein (lanes 2–5). eIF-5A binds to
eight polypeptide bands as revealed by anti-GST antibodies (in-
dicated by dots, lane 2). Membranes were then stripped of bound
antibodies and reprobed with antibodies to CRM1 (lane 3), to a
family of nucleoporins (mAb 414, lane 4), and to actin (lane 5).
The eIF-5A binding proteins identified are indicated at the right.
(B) To analyze interactions of eIF-5A with nuclear proteins in
solution, glutathione–Sepharose beads coupled to GST–eIF-5A
(lanes 1–5) or to GST (lanes 6 and 7) were incubated with the ex-
tract of 150 manually isolated nuclei of Xenopus oocytes. The
bound pelleted proteins were analyzed by immunoblotting (lanes
1–3) with antibodies to CRM1 (lane 1), nucleoporins (lane 2),
and actin (lane 3), or by silver staining (lanes 4 and 6). The un-
bound proteins were visualized by silver staining (lanes 5 and 7).
Molecular mass standards are indicated in kD.
Figure 5. Actin is a constituent of the nucleoplasmic NPC-associ-
ated filaments as shown by immungold electron microscopy.
Manually isolated nuclear envelopes from Xenopus (A) and
Pleurodeles (B) oocytes were incubated with antiactin antibody
2G2 followed by secondary antibodies coupled to 12-nm gold
particles. The nuclear filaments extending from the NPCs are
particularly prominent in Pleurodeles oocytes (B). The occa-
sional presence of mitochondria (M) clearly identifies the cyto-
plasmic side of the nuclear envelope. ONM, outer nuclear mem-
brane; INM, inner nuclear membrane. Bars, 0.3 mm. 
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and not exportin4, which has recently been described as a
novel importin-
 
b
 
 family member with a similar molecular
weight to CRM1/exportin1 (Lipowsky et al., 2000). Fi-
nally, these interactions were also confirmed in solution by
pull-down experiments using wt GST–eIF-5A protein and
extracts of manually isolated nuclei of 
 
Xenopus
 
 oocytes
(Fig. 4 B, lanes 1–3). The corresponding silver-stained gel
showing the pattern of bound (Fig. 4 B, lane 4) and un-
bound (Fig. 4 B, lane 5) proteins to GST–eIF-5A demon-
strated the specificity of this binding assay. Only a very
few specific binding proteins were visible (Fig. 4 B, com-
pare lanes 4 and 5). Furthermore, an additional control ex-
periment was performed using GST alone. The pattern of
GST-bound (Fig 4 B, lane 6) and unbound (Fig. 4 B, lane
7) proteins are shown. As expected, no GST-bound nu-
clear envelope–associated proteins were detected. Of
note, the predominant signal that was observed in this ex-
periment is BSA, an ingredient of the used blocking buffer
(Fig. 4 B, compare lanes 6 and 7).
Inspection of the overlay blot shown in Fig. 4 A (lane 2)
also indicated an affinity of eIF-5A for three proteins of
relatively low molecular mass (ranging from 
 
z
 
30 to 
 
z
 
45
kD). These eIF-5A interacting proteins were analyzed by
mass spectrometry and peptide sequencing. The data ob-
tained identified the 
 
z
 
45-kD protein as actin. This result
was confirmed by reprobing the nitrocellulose filters with
antiactin antibody 2G2 (Fig. 4 A, lane 5) as well as by pull-
down experiments (Fig. 4 B, lane 3). Additional solution
binding studies using purified actin monomers and nuclear
extracts from 
 
Xenopus
 
 oocyte nuclei confirmed that actin
indeed binds to eIF-5A. Under these conditions, actin also
interacted with the nucleoporin nup62 (data not shown).
Then, we characterized the nuclear envelope association
of actin at the ultrastuctural level by preembedding immu-
nogold electron microscopy. To this end, nuclear enve-
lopes were manually isolated from 
 
Xenopus or Pleurodeles
oocytes and incubated with antiactin antibody 2G2 (Gon-
sior et al., 1999), followed by gold-coupled secondary anti-
bodies. Interestingly, actin was found specifically at the
nucleoplasmic face of the NPC and along the nucleoplas-
mic NPC-attached fibrils that are particularly prominent
in Pleurodeles oocytes (Fig. 5, A and B). It should be
stressed that the NPC-associated fibers are not actin fila-
ments (F-actin). When isolated nuclear envelopes from
Xenopus and Pleurodeles oocytes were incubated in the
Figure 6. Antibodies against actin inhibit nuclear export of GST–
Rev–NES, GST–PKI–NES, RRE RNA, and CTE RNA in Xeno-
pus oocytes. (A) Oocyte injection protocol. Nuclear (N) and
cytoplasmic (C) fractions were manually isolated. (B and E) Pro-
teins were separated by 18% SDS-PAGE and analyzed by
immunoblotting with antibodies to GST and BSA. The exclusive
presence of the nonexportable protein BSA in the nuclear frac-
tions confirms the accuracy of the injections. (B) The nuclear ex-
port of GST–Rev–NES is strongly inhibited by antibodies against
actin (lane 4) but not by control IgM (lane 2). (E) Antiactin anti-
bodies also block the nuclear export of GST–PKI–NES (lane 4),
whereas, in contrast, it is exported in the presence of control IgM
(lane 2). Molecular mass standards are indicated in kD. (C and
D) RNA separated by 8 M 6% acrylamide urea gels and visual-
ized by autoradiography. (C) In the presence of antiactin anti-
bodies, the Rev-mediated export of RRE RNA is inhibited (com-
pare lanes 2 and 4). (D) Antiactin antibodies also inhibit the
export of CTE RNA (compare lanes 2 and 4). As expected, the
mutant CTE M2/M11 is not exported (lanes 1 and 3). The nuclear
localization of the nonexportable U6 RNA confirms the accuracy
of the nuclear injections.The Journal of Cell Biology, Volume 152, 2001 904
presence of Ca21 with gelsolin, an actin severing protein,
the NPC-associated filaments remained intact (data not
shown). Thus, although actin is clearly associated with
these filaments, their integrity is not based on polymerized
actin but must involve other proteins.
Actin Participates in Nuclear Export Processes
To examine whether or not nuclear actin is functionally in-
volved in nuclear export, first, we tested the effect of anti-
actin antibodies on the nuclear export of GST–Rev–NES
and GST–PKI–NES fusion proteins as well as on Rev-medi-
ated RRE RNA export and Rev-independent MPMV
CTE RNA export. For this, Xenopus oocyte nuclei were
microinjected as outlined above and depicted in Fig. 6 A.
These experiments demonstrated that antibodies directed
against actin are efficient export inhibitors when delivered
to the nuclear interior. In fact, Rev–NES and Rev-medi-
ated RRE RNA export (Fig. 6, B and C, respectively) was
as efficiently abrogated by these antibodies as the nuclear
export of the MPMV CTE (Fig. 6 D) and of the PKI–NES
(Fig. 6 E). Upon injection into the cytoplasm, the antibod-
ies had no effect on nuclear export (data not shown).
Since nuclei of somatic cells and amphibian oocytes are
usually not stained by fluorescent phalloidin, a specific
marker of F-actin in immunofluorescence microscopy, it is
possible that nuclear actin may exist in an unpolymerized
or oligomeric form that is not recognized by phalloidin or
organized in higher order structures different from F-actin
(Gonsior et al., 1999). To further test the role of actin po-
lymerization in nuclear export, we studied the effect of
two actin-binding drugs with different specificities. The
toxin latrunculin binds to G-actin and prevents its poly-
merization (Coue et al., 1987). Microinjection of latruncu-
lin B into oocyte nuclei inhibited not only the export of
Rev–NES (Fig. 7 B, lanes 3 and 4) and RRE RNA (data
not shown) but also the export of PKI–NES (Fig. 7 C,
lanes 3 and 4) and of the MPMV CTE (data not shown).
In contrast, nuclear injection of swinholide A, a drug that
severs F-actin and stabilizes actin dimers (Bubb et al.,
1995), did not inhibit nuclear export (Fig. 7, B and C, lanes
5 and 6). These results support the idea that a soluble form
of nuclear actin, rather than F-actin, participate in multi-
ple nuclear export pathways in Xenopus oocytes.
Since these data provided evidence for a novel export
function of actin, we also wanted to test whether these re-
sults could be confirmed in somatic cells. Therefore, we
microinjected nuclei of Vero cells with recombinant nu-
clear export substrate in which Rev–NES–GST was fused
to the GFP. This GFP–Rev–NES–GST fusion protein al-
lows the monitoring of Rev–NES-mediated nuclear export
in live cells (Rosorius et al., 1999a). GFP-specific fluores-
cence and phase contrast images were taken immediately
and 30 min after injection. Coinjection of nonspecific IgM
did not interfere with Rev–NES-mediated nuclear export
(Fig. 8, A9 and B9). However, coinjection of antiactin anti-
bodies completely abrogated the nucleocytoplasmic trans-
location of the export substrate (Fig. 8, C9 and D9), con-
firming the data raised in Xenopus oocytes. As expected,
antiactin antibodies were able to effectively block the nu-
clear export of GST–PKI–NES (data not shown), again
confirming the data obtained in Xenopus oocytes.
To analyze the actin requirement for nuclear export in
more detail, we next wanted to establish an in vitro nu-
clear export system. It has previously been shown that ex-
tracts prepared from activated amphibian eggs are capable
of assembling purified DNA or chromatin into synthetic
nuclei, which accumulate soluble karyophilic proteins
from the surrounding medium by signal- and energy-
dependent nuclear import processes (for review see New-
meyer and Wilson, 1991). However, transport in the oppo-
site direction, i.e., nuclear export of macromolecules, has
not yet been observed, and it is therefore generally be-
lieved that these in vitro systems are export deficient. In
fact, our initial attempts to establish such a Rev export in
vitro system failed and confirmed this notion. However,
after having identified actin as a factor involved in nuclear
export, we realized that standard protocols for the prepa-
ration of egg extract include the drug cytochalasin B in or-
Figure 7. Different effects of actin-binding drugs on nuclear ex-
port of GST–Rev–NES and GST–PKI–NES. (A) Oocyte injec-
tion protocol. 1 h after nuclear injection of latrunculin B,
swinholide A or PBS (control) and the export substrate GST–
Rev–NES or GST–PKI–NES, together with BSA, were microin-
jected into oocyte nuclei. 2 h later, oocytes were manually dis-
sected into nuclear (N) and cytoplasmic (C) fractions. (B and C)
Proteins were separated by 18% SDS-PAGE, and blots were an-
alyzed with antibodies to GST and BSA. A substantial fraction of
the injected export substrate migrates into the cytoplasm in the
presence of PBS (lane 2) or swinholide A (lane 6). In contrast,
the export substrate remains exclusively in the nuclei in presence
of latrunculin B (lane 3). Detection of BSA in the nuclei confirms
the specificity of the nuclear injections.Hofmann et al. Role of Actin in Nuclear Export 905
der to prevent actin polymerization and gelation of the
extract (Newmeyer and Wilson, 1991). The effect of cy-
tochalasins on actin dynamics is quite complex and arises
not only from an inhibition of the elongation of F-actin but
also from an alteration of the properties of actin mono-
mers (Sampath and Pollard, 1991). To clarify whether the
presence of cytochalasin B might interfere with nuclear
export processes in vitro, we performed the after experi-
ments. First, we isolated nuclei from HeLa–Rev cells,
which is a cell line that constitutively expresses high levels
of nuclear HIV-1 Rev protein (Wolff et al., 1995). The iso-
lated nuclei were then incubated for 1 h in Xenopus egg
extracts, which were prepared with or without the addition
of cytochalasin B. Subsequently, the nuclei were centri-
fuged onto coverslips, washed, and analyzed by immuno-
fluorescence microscopy with antibodies against Rev. Egg
extracts that contained cytochalasin B did not support the
nuclear export of Rev, irrespective of whether or not an
energy-regenerating system was present (Fig. 9, A and B).
In striking contrast, however, nuclear export of Rev was
easily detectable when egg extracts lacking cytochalasin B
were used (Fig. 9 C). This transport appeared to be an ac-
tive and CRM1–exportin 1-mediated process, since it de-
pended critically on the presence of an energy-regenerat-
ing system (Fig. 9 D) and was blocked by leptomycin B
(data not shown). The ability of the isolated nuclei to pro-
mote nuclear import was confirmed by analyzing the im-
port of BSA–SV40T–FITC. This transport substrates was
efficiently taken up by the isolated nuclei in egg extract
prepared with or without cytochalasin B (data not shown).
Together, our data demonstrate that nuclear export of
Rev can be reproduced in a cell-free system provided that
the egg extract is prepared without the actin-binding drug
cytochalasin B.
Discussion
The bidirectional transport of macromolecules between the
nucleus and cytoplasm across the NPC is an energy-depen-
dent and highly selective process. A family of transporter
proteins known as importins or exportins mediate this intra-
cellular movement of proteins and RNA (Corbett and Sil-
ver, 1997; Izaurralde and Adam, 1998; Görlich and Kutay,
1999; Nakielny and Dreyfuss, 1999). In contrast to nuclear
import processes, the export of macromolecules from the
nucleus is less well understood. Although some general
characteristics of nuclear export have been established and
some components of the export machinery have already
been identified, their exact mode of action is not clear.
It has previously been reported that eIF-5A is required
in somatic cells specifically for the nucleocytoplasmic
translocation of the Rev/Rex class of retroviral RNA nu-
clear export factors (Ruhl et al., 1993; Katahira et al., 1995;
Bevec et al., 1996). Moreover, inhibition studies in somatic
Figure 8. Inhibition of nuclear export of
GFP–Rev–NES–GST fusion protein by
antiactin antibodies in cultured Vero
cells. A mixture of GFP–Rev–NES–GST
fusion protein, together with either con-
trol IgM (A and B), or antiactin antibod-
ies (C and D) was microinjected into nu-
clei of Vero cells. Phase–contrast images
(left) and GFP fluorescence (right) were
recorded at the indicated postinjection
time points. The export substrate is effi-
ciently translocated from the nucleus to
the cytoplasm in the presence of control
IgM (A9 and B9). In contrast, coinjected
antiactin antibodies completely prevent
nuclear export (C9 and D9). Microin-
jected cells are denoted by arrows. Bar,
20 mm.The Journal of Cell Biology, Volume 152, 2001 906
cells suggested that eIF-5A acts before or simultaneously
with CRM1/exportin1 in the nuclear export of Rev and
Rex (Elfgang et al., 1999). In agreement with the notion
that eIF-5A is a protein that is part of this specific nuclear
export pathway, we were able to demonstrate that eIF-5A
accumulates in particular at the NPC-associated nucleo-
plasmic fibrils in Xenopus oocytes and somatic cells, inter-
acts with the general export receptor CRM1/exportin1,
and is by itself exported from the nucleus to the cytoplasm
in a leptomycin B–sensitive manner (Rosorius et al.,
1999b). In particular, the latter finding that eIF-5A is ac-
tively exported from the nucleus has been confirmed by a
recent study (Lipowsky et al., 2000). In this work, it was
demonstrated that eIF-5A also interacts with a novel ex-
port receptor, named exportin4. Importantly, binding of
eIF-5A to exportin4 was shown to depend on the hypusine
modification in eIF-5A, with the implication that hypusine
is required for nuclear export of eIF-5A. On the other
hand, however, unmodified eIF-5A has been shown to be
efficiently exported from the nucleus to the cytoplasm in
microinjected somatic cells (Rosorius et al., 1999b) and
Xenopus oocytes (this study), as well as in permeabilized
cells (Lipowsky et al., 2000). Moreover, human eIF-5A is
fully functional in yeast strains that are disrupted for
HYP2 encoding the yeast homologue of eIF-5A (Schwel-
berger et al., 1993; Magdolen et al., 1994), despite the fact
that exportin4 is apparently not present in this organism
(Lipowsky et al., 2000). In summary, these data suggest
that the unique hypusine modification is not essential for
nuclear export of eIF-5A and that it is possible that eIF-
5A interacts with multiple export receptors (e.g., CRM1/
exportin1 and exportin4). It remains to be investigated in
future studies whether or not the interaction of eIF-5A
with different export receptors reflects a distinct regula-
tion of a specific nuclear export pathways in response to
specific physiological conditions.
The results of this study clearly demonstrate that nu-
clear export of Rev and RRE RNA in Xenopus oocytes is
also dependent on eIF-5A. In contrast, however, eIF-5A is
not essential for CTE-mediated RNA export, which is in
perfect agreement with previously published data that re-
ported that the CTE RNA export is distinctly regulated
when compared with Rev/Rex–mediated RNA export
(Pasquinelli et al., 1997; Bogerd et al., 1998; Kang and
Cullen, 1999; Zolotukhin and Felber, 1999).
The finding that the eIF-5A–M14 mutant protein is un-
able to bind to the general export receptor CRM1/
exportin1, and that this correlates with an export-deficient
phenotype of this protein, suggested a mechanism in which
eIF-5A may act as an adapter that targets the Rev–NES
to the nucleoplasmic face of the NPC and mediates effi-
cient binding to CRM1/exportin1. CRM1/exportin1 and
associated components (e.g., Ran) then translocate the
Rev-NES/eIF-5A–containing ribonucleoprotein particle
through the pore channel. Indeed, our subsequent in vitro
binding studies demonstrated that efficient Rev-NES–
CRM1 complex formation was only mediated by wt eIF-
5A but not by the eIF-5A–M14 mutant protein.
The eIF-5A protein was originally detected as a poten-
tial Rev cofactor in HeLa nuclei using reversible cross-
linker molecules in combination with structurally flexible
Rev–NES peptide mimics (Ruhl et al., 1993). The binding
experiments in this study were performed with GST–Rev–
NES fusion proteins in which a structurally flexible glycine
linker element separates the GST from the NES moiety
(Elfgang et al., 1999). It should be noted that when full-
length Rev protein was used in in vitro binding studies, an
interaction with eIF-5A was only observed when Rev was
bound to the RRE RNA at concentrations that allowed
the formation of a dimeric Rev–specific complex (Bevec et
al., 1996). In contrast, no in vitro interaction of Rev with
eIF-5A was detected in a study in which Rev–RRE ratios
were used that favored the formation of monomeric or
multimeric Rev–specific complexes on the RRE RNA
(Henderson and Percipalle, 1997). More recent  in vitro
binding studies using full-length recombinant Rev protein
and cytoplasmic HeLa cell extracts (as a source of eIF-5A)
did also not detect binding of eIF-5A to Rev (Lipowsky et
al., 2000). However, this experimental design is not suit-
able for the investigation of the interaction of full-length
Rev protein with any nuclear export factor, since it ne-
glects the well established fact that Rev homomultimer
formation on the RRE RNA is essential for Rev function
(Pollard and Malim, 1998). As shown previously (Elfgang
et al., 1999) and in this study, the requirement of RRE
RNA binding and subsequent multimerization can appar-
ently be overcome by using structurally flexible Rev–NES
mimics. The combined data may therefore suggest that
dimerization of Rev protein on its RRE RNA target is re-
quired for its interaction with nuclear export factors. In
particular, a study in which Rev in vitro multimerization
was investigated in combination with functional cell-based
assays indeed concluded that two monomeric Rev proteins
Figure 9. Nuclear  export of Rev in a cell-free system. Nuclei
were isolated from a HeLa cell line that constitutively expresses
high levels of nuclear HIV-1-Rev and were incubated in Xenopus
egg extract with or without cytochalasin B and an energy-regen-
erating system. After 1 h, nuclei were processed for immunofluo-
rescence with antibodies to Rev (A99–D99) and counterstained
with the DNA-specific dye Hoechst (A9–D9). In the absence of
cytochalasin B and the presence of energy, Rev is exported from
the nuclei (C99). The corresponding phase–contrast images are
shown (A–D). Bars, 15 mm.Hofmann et al. Role of Actin in Nuclear Export 907
bound to the RRE RNA is sufficient for biological activity
(Daly et al., 1993b). However, future studies are required
to elucidate the exact protein composition of Rev-contain-
ing export complexes.
The concept that eIF-5A facilitates the interaction of
the Rev–NES with CRM1/exportin1 is in full agreement
with recent studies in which the binding affinities of Rev–
NES to CRM1/exportin1 were investigated using recombi-
nant proteins. When RRE RNA-bound Rev protein was
incubated together with CRM1/exportin1 and RanGTP in
RNA gel retardation assays, only an extremely poor level
of complex formation was detected (Askjaer et al., 1998).
It appears that, in these types of experiments, ,1% of the
preformed RRE–Rev ribonucleoprotein complexes in-
teracted with recombinant CRM1/exportin1 and Ran-
GTP. Moreover, in another study, efficient interaction of
CRM1/exportin1 with RanGTP in the presence of Rev–
NES peptides was only observed when CRM1/exportin1
derived from reticulocyte lysates was used (Fornerod et
al., 1997a). Reticulocyte extracts contain high levels of
eIF-5A (Schatz et al., 1998). Interestingly, when CRM1/
exportin1 was produced by translation in an E. coli–
derived lysate (which does not contain eIF-5A), binding
was only observed using the PKI-derived NES (Fornerod
et al., 1997a), again suggesting that factors in addition to
RanGTP are required for efficient Rev-NES–CRM1 inter-
action. Finally, quantification of the Rev-NES–CRM1 af-
finity using an assay that measures the hydrolysis of Ran-
bound GTP upon complex formation (RanGAP assay)
clearly demonstrated that the Rev–NES displays an ex-
tremely low affinity for CRM1/exportin1, at a level that is
almost indistinguishable from that of an export-deficient
mutant NES (Askjaer et al., 1999). In sharp contrast, how-
ever, complex formation with CRM1/exportin1 was clearly
observed when the PKI–NES was used in this assay
(Askjaer et al., 1999). In this context it is also important to
reemphasize that inhibition of eIF-5A has previously been
shown to block Rev-NES–mediated but not PKI-NES–
mediated nuclear export in somatic cells (Elfgang et al.,
1999), a fact that was reproduced in Xenopus oocytes (this
study). Clearly our data showing that eIF-5A mediates
Rev-NES–CRM1 interaction provides an explanation for
these findings. Moreover, our data reveal the mode of ac-
tion of eIF-5A mutant proteins (e.g., M14) that have been
shown to efficiently block HIV-1 replication in human T
cells when constitutively expressed in trans (Bevec et al.,
1996; Junker et al., 1996).
To analyze interactions of eIF-5A with components of
the NPC, we performed in vitro  binding studies using
overlay blot assays and precipitation analyses. We were
able to identify specific interactions between eIF-5A and
the Xenopus oocyte nucleoporins nup153, nup98, nup62,
and CAN/nup 214 (for review see Stoffler et al., 1999). Al-
though the functional contribution of these interactions to
eIF-5A export remains to be established, it is certainly in-
triguing that this assay only detected nucleoporins that
have been implicated in nuclear export pathways (Bastos
et al., 1995; Fornerod et al., 1997b; Powers et al., 1997;
Askjaer et al., 1999; Kehlenbach et al., 1999; Nakielny et
al., 1999; Pritchard et al., 1999; Ullman et al., 1999; Bachi
et al., 2000), whereas other FG repeat–containing nucle-
oporins like RanBP2 are not detected. In this context it is
also important to note that a series of recent studies in-
deed demonstrated the direct participation of CAN/
nup214, nup153, and nup98 in the nuclear export of Rev
and Rev-mediated viral mRNA export (Bogerd et al.,
1998; Ullman et al., 1999; Zolotukhin and Felber, 1999).
Thus, the identification of NPC-associated proteins that
interact with the Rev cofactor eIF-5A appears to be a
promising experimental approach to detect novel factors
that participate in nuclear export of Rev. In fact, in over-
lay assays and in solution binding studies using isolated
nuclei from Xenopus oocytes, eIF-5A interacted not only
with a specific set of nucleoporins but also with actin. By
immunogold electron microscopy, we could exclude that
the nuclear envelope–associated actin represented cyto-
plasmic contamination since it localized specifically to the
nucleoplasmic face of the NPCs and the attached pore fila-
ments. Amphibian oocyte nuclei contain high concentra-
tions of nonmuscle b- and g-actin, mostly in a soluble, i.e.,
unpolymerized or short polymer, form (Scheer et al., 1984;
Ankenbauer et al., 1989; Gonsior et al., 1999). Our finding
that eIF-5A colocalizes together with nuclear actin (this
study) and nup153 (Rosorius et al., 1999b) at the filamen-
tous arrays extending from the nucleoplasmic side of
NPCs is in perfect agreement with the in vitro binding
studies and, furthermore, suggests that the nucleoplasmic
NPC filaments serve as docking sites for RRE RNA con-
taining viral export complexes before nuclear exit.
Even with the inherent problems of cytoplasmic contam-
ination, it is now generally accepted that actin is present
not only in oocyte nuclei but also in the interphase nuclei
of somatic cells (Scheer et al., 1984; Sahlas et al., 1993;
Gonsior et al., 1999; Rando et al., 2000). Given its abun-
dance and widespread occurrence, it is quite likely that nu-
clear actin is involved in specific nuclear processes that are,
however, not necessarily dependent on filament formation.
Among other functions (Gonsior et al., 1999; Rando et al.,
2000), nuclear actin has been implicated in transcription of
cellular and viral genes (Egly et al., 1984; Scheer et al.,
1984; Burke et al., 1998) and chromatin remodelling events
(Zhao et al., 1998). Based on nuclear injection experiments
of antiactin antibodies and actin-binding drugs, this study
now shows that nuclear actin also may be involved in the
later stages of gene expression, namely the NPC-mediated
transport of RNA out of the nucleus. This view is further
corroborated by a recent study in which the authors also
provide evidence for a functional involvement of nuclear
actin in the nuclear export of Rev-dependent HIV-1 pre-
mRNA (Kimura et al., 2000). However, although these au-
thors emphasize the importance of a filamentous form of
nuclear actin, our data suggest that it is the unpolymerized
or short polymer form of nuclear actin that functions in nu-
clear export processes (see below).
At the moment, we do not know whether or not actin is
a general cofactor that also participates in the nuclear ex-
port pathways of cellular RNA species. Nonetheless, our
data demonstrate that actin plays a functional role in at
least two distinct export pathways accessed by viral RNAs,
the Rev-dependent RRE RNA, and the TAP-dependent
CTE RNA export. Since TAP also contributes to the ex-
port of cellular mRNAs (Grüter et al., 1998; Braun et al.,
1999; Görlich and Kutay, 1999; Nakielny and Dreyfuss,
1999), it is conceivable that actin could likewise function inThe Journal of Cell Biology, Volume 152, 2001 908
this pathway. Furthermore, we show that nuclear actin
participates in the nuclear export of the eIF-5A–indepen-
dent, CRM1-dependent NES of PKI. Finally, it should be
stressed that the inhibition of nuclear export by antibodies
to actin was not restricted to oocytes but appears to be a
general phenomenon as it was also observed in cultured
mammalian cells.
Our findings that (a) actin is located at the inner pore
fibrils, (b) actin interacts in vitro with the export factor
eIF-5A and with the nucleoporin nup62, and (c) Rev and
TAP-mediated nuclear export of viral RNAs as well as nu-
clear export of PKI can be inhibited by introducing either
antiactin antibodies or the actin-binding drug latrunculin
B into the cell nucleus, indicate a novel and unexpected
role for nuclear actin. Since we observed the export-inhib-
itory effect with both agents, we conclude that it is caused
by direct targeting and functional inactivation of nuclear
actin rather than by more indirect effects such as precipita-
tion of nuclear actin. Nuclear import was not inhibited
under the same experimental conditions (not shown),
indicating that the injected antibodies did not cause a non-
specific steric inhibition of transport complexes at the
pore. Several lines of evidence suggest that it is the unpo-
lymerized or short polymer form of nuclear actin that is in-
volved in nuclear export rather than F-actin. First, most of
the nuclear actin of Xenopus oocytes exists in a soluble, al-
though polymerization-competent form (Scheer et al.,
1984; Ankenbauer et al., 1989). Second, fluorescent phal-
loidin, which is selective for F-actin, does not stain F-actin
in the nuclei of Xenopus oocytes and cultured vertebrate
cells under normal conditions, i.e., without experimental
manipulations (Sahlas et al., 1993; Gonsior et al., 1999).
Third, the antiactin antibody we have used for the micro-
injection experiments (2G2) does not recognize native
F-actin but is selective for a specific conformational state
of actin that is predominantly found in nuclei (Gonsior et
al., 1999). It is tempting to speculate that actin dimers,
which have been reported to assume a conformation not
present in polymerized F-actin (lower dimer or LD [Mil-
lonig et al., 1988]), are the major targets of this antibody.
Fourth, Rev and PKI export are not affected by injection
of swinholide A into nuclei. This actin-binding drug severs
F-actin and stabilizes actin dimers (Bubb et al., 1995),
demonstrating that neither the absence of F-actin nor a
decrease in the G-actin level affects the nuclear export
pathway. Finally, Rev and PKI export are inhibited by la-
trunculin B, which sequesters G-actin monomers and pre-
vents its polymerization (Coue et al., 1987). The opposing
effects of latrunculin B and swinholide A support the con-
cept that actin dimers function in nuclear export.
The critical role of actin in the Rev export pathway was
also demonstrated in a cell-free system using Xenopus egg
extract. When we omitted cytochalasin B, which is nor-
mally added to the extract as a gelation inhibitor (New-
meyer and Wilson, 1991), Rev was efficiently exported in an
energy-dependent manner from incubated isolated nuclei.
Since the interactions of cytochalasin with actin are com-
plex and involve capping of the barbed ends of F-actin and
hydrolysis of the monomeric ATP–actin pool (Sampath
and Pollard, 1991), the interpretation of the inhibitory
mechanism of cytochalasin B in this experimental system
is difficult. More importantly, the cell-free nuclear export
assay described here should provide the means to further
explore the export pathway of Rev–RRE and possibly also
of cellular RNAs since the extract can be easily manipu-
lated and nuclear export monitored by simple immunoflu-
orescence microscopy. Furthermore, this model system
should help to clarify whether or not the ability of soluble
actin to shuttle between the nucleus and the cytoplasm
(Wada et al., 1998) is linked to nuclear export processes.
However, we consider this quite unlikely in view of the ob-
servation that the nuclear export of G-actin is inhibited by
the drug leptomycin B (Wada et al., 1998), whereas the
TAP–CTE export pathway is not affected (Otero et al.,
1998). We have shown that nuclear actin participates in
the export of CTE RNA. Obviously, the shuttling poten-
tial of actin is of no relevance in this context, since the
CTE RNA export resists inhibition by leptomycin B.
In summary, our data demonstrate that actin accumu-
lates at NPC-attached nucleoplasmic filaments and can
contribute to the nuclear export of multiple export sub-
strates. We propose that unpolymerized nuclear actin is
critically involved in the assembly of multiprotein export
complexes. Investigation of the exact functional role of ac-
tin as part of the NPC-associated nuclear export machin-
ery is a major research goal for the future.
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